CliffBio

Long Grove

Patent cliffs & loss of exclusivity

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDENOREPINEPHRINE BITARTRATESmall mol.Jan 2038
  2. NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDENOREPINEPHRINE BITARTRATESmall mol.Jan 2038
  3. NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDENOREPINEPHRINE BITARTRATESmall mol.Jan 2038
  4. CALCITRIOLCALCITRIOLSmall mol.—
  5. CALCITRIOLCALCITRIOLSmall mol.—
  6. CARBOPROST TROMETHAMINECARBOPROST TROMETHAMINESmall mol.—
  7. DIAZEPAMDIAZEPAMSmall mol.—
  8. METHADONE HYDROCHLORIDEMETHADONE HYDROCHLORIDESmall mol.—
  9. TRIAMCINOLONE ACETONIDETRIAMCINOLONE ACETONIDESmall mol.—
  10. AK-FLUOR 10%FLUORESCEIN SODIUMSmall mol.—
  11. AK-FLUOR 25%FLUORESCEIN SODIUMSmall mol.—
  12. DALBAVANCIN HYDROCHLORIDEDALBAVANCIN HYDROCHLORIDESmall mol.—
  13. EDARAVONEEDARAVONESmall mol.—
  14. ERIBULIN MESYLATEERIBULIN MESYLATESmall mol.—
  15. SODIUM BICARBONATESODIUM BICARBONATESmall mol.—
  16. VASOPRESSIN IN SODIUM CHLORIDE 0.9%VASOPRESSINSmall mol.—
  17. VASOPRESSIN IN SODIUM CHLORIDE 0.9%VASOPRESSINSmall mol.—
  18. VASOPRESSIN IN SODIUM CHLORIDE 0.9%VASOPRESSINSmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.